Download Free Sample Report

Liquid Formulations Drug Delivery Market, Global Outlook and Forecast 2022-2028

Liquid Formulations Drug Delivery Market, Global Outlook and Forecast 2022-2028

  • Published on : 13 October 2022
  • Pages :108
  • Report Code:SMR-7440961

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
This report contains market size and forecasts of Liquid Formulations Drug Delivery in Global, including the following market information:
  • Global Liquid Formulations Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global top five companies in 2021 (%)
The global Liquid Formulations Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Suspensions Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liquid Formulations Drug Delivery include 3M, Merck & Co, Crescita Therpeautics, Novartis International, Boehringer Ingelheim, Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb and Lead Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Liquid Formulations Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liquid Formulations Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liquid Formulations Drug Delivery Market Segment Percentages, by Type, 2021 (%)
  • Suspensions
  • Solutions
Global Liquid Formulations Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liquid Formulations Drug Delivery Market Segment Percentages, by Application, 2021 (%)
  • Home Care Settings
  • Hospitals & Clinics
  • Burn Centers
  • Other Facilities
Global Liquid Formulations Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liquid Formulations Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
  • Key companies Liquid Formulations Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Liquid Formulations Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
  • 3M
  • Merck & Co
  • Crescita Therpeautics
  • Novartis International
  • Boehringer Ingelheim
  • Pfizer
  • Teva Pharmaceuticals
  • Bristol Myers Squibb
  • Lead Chemical
  • Purdue Pharma
  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson Private
  • GlaxoSmithKline
  • Bausch Health Companies
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris